There were 603 press releases posted in the last 24 hours and 169,306 in the last 365 days.

Animal Vaccines Market Analysis Report, 2018-2025 - World Market to be Valued at $12.84 Billion by 2025

/EIN News/ -- Dublin, Oct. 22, 2019 (GLOBE NEWSWIRE) -- The "Animal Vaccines Market by Product Type and Animal Type: Global Opportunity Analysis and Industry Forecast, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

According to this report, the global animal vaccines market accounted for $8,059 in 2017, and is estimated to reach $12,845 million by 2025, registering a CAGR of 5.9% from 2018 to 2025.

Increase in adoption of companion animals in the developing countries is the major factor that drives the growth of this market. The market has witnessed moderate growth in recent years due to emerging diseases that affect livestock. The outbreak of epidemics results in severe mass wipeouts of animals, and is a growing concern for the industries dependent on products obtained through farm animals. Moreover, zoonotic diseases that affect animals pose a threat to the public health, hence avoiding transmission of such diseases via vaccination is a significant factor in disease management.

Based on animal type, the animal vaccines market is classified into companion animals, cattle, pigs, poultry, and sheep. The companion animals segment is subsegmented into dogs, cats, and others. Cattle segment generated maximum revenue in 2017 attributable to increase in consumption of meat, milk, and dairy products, making sustainable animal health a vital aspect in disease management. However, the companion animal segment is anticipated to grow at a faster pace during the forecast period.

By product type, the animal vaccines market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. Attenuated vaccines segment dominated the product type segment with maximum share in 2017. Attenuated vaccines can provide stronger immunity as compared to other vaccines, which positively contributes toward the market growth. However, DNA vaccines is expected to be the fastest growing segment.

In 2017, North America accounted for the highest revenue in the global animal vaccines market. Asia-Pacific is expected to show highest growth rate. Rise in disposable income, increase in animal healthcare expenditure, and surge in adoption of companion animals are the major factors that drive the growth of animal vaccines market in Asia-Pacific.

The report provides a comprehensive analysis of the key players operating in the global animal vaccines market. These players include Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, and Anicon Labor GmbH. The other players operating in the global animal vaccines market include Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, and Arko Laboratories, Ltd.

Key Findings of the Animal Vaccines Market

  • DNA vaccines segment is projected to grow fastest during the analysis period
  • Cattle vaccines generates highest revenue, and is expected to continue its dominance during the forecast period
  • North America dominated the global animal vaccines market, and projected to grow at a CAGR of 5.3%
  • China is expected to grow at the highest CAGR of 7.7% in Asia-Pacific
  • The companion animal segment exhibits fast-paced growth rate, registering a CAGR of 6.4%

For more information about this report visit https://www.researchandmarkets.com/r/by1n5e

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo

Distribution channels: Culture, Society & Lifestyle, Science


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.